Oncology

EVIDENCE-BASED ONCOLOGY

Mice administered FOLFIRINOX through the implantable device had greater tumor regression and lower tissue toxicity.
As physicians and researchers question whether certain treatments for early signs of breast cancer are necessary, the first large US study will seek to determine the best way to manage ductal carcinoma in situ.
Ensuring rapid, appropriate, and sustainable access to immuno-oncology therapies for patients in Europe: what role can policies play?
The panel members that have proposed the recommendations have found clinical utility for several genomic tests to guide clinical decision in women with early stage breast cancer.
Moderator Scott Gottlieb, MD, ended the Oncology Stakeholder Summit, Fall 2015, by asking the panel for closing statements.

EVENTS

May 15-19, 2015
New Orleans, LA
May 29-June 2, 2015
Chicago, IL
June 11-14, 2015
Vienna, Austria
June 17-20, 2015
Lugano, Switzerland
Feature
Diabetes Compendium
Oncology Compendium
COPD Compendium
Reimbursement Compendium
$AD300x250BB$
$vacMongoViewPlus$